A detailed history of Ci Private Wealth, LLC transactions in Genmab A/S stock. As of the latest transaction made, Ci Private Wealth, LLC holds 10,483 shares of GMAB stock, worth $234,085. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,483
Holding current value
$234,085
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.13 - $30.27 $263,437 - $317,320
10,483 New
10,483 $263,000
Q3 2023

Nov 03, 2023

BUY
$35.27 - $42.24 $20,985 - $25,132
595 Added 7.06%
9,020 $318,000
Q2 2023

Aug 10, 2023

BUY
$37.4 - $42.94 $10,958 - $12,581
293 Added 3.6%
8,425 $320,000
Q1 2023

May 15, 2023

BUY
$34.88 - $43.22 $283,644 - $351,465
8,132 New
8,132 $307,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $14.7B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.